Ingrid Skelton Kockum
Professor of Genetic Epidemiology with focus on Multiple Sclerosis 2016-present
Director of Doctoral studies at Department of Clinical Neurosciences, Karolinska Institutet 2019-present
Vice-chair Nordic society for human genetics and precision medicine .
259 publications and 10 reviews – Web of Science h index = 50 Google Scholar h index = 63, i index = 199 (as March 2022)
Currently receives research funding from Swedish Medical research Council, Horizon 2020, Vinnova, Hjärnfonden, National MS society (USA), Margaretha af Ugglas foundation and Karolinska Institutet
Currently supervises 2 PhD student and co-supervises 4 PhD students
Professor Ingrid Kockum grew up on a farm in Skåne in Southern Sweden. She completed her undergraduate studies in 1989 at Newnham College, Cambridge, UK, in natural sciences majoring in zoology with focus in molecular biology. She started her PhD studies in immunogenetics of type 1 diabetes at Lund University, Sweden and University of Washington, Seattle, USA, but defended her thesis at Karolinska Insitutet in 1995. She continued her research in the genetics of type 1 diabetes as a postdoc at the Wellcome Trust Center for Human Genetics, Oxford University, UK (1996-1997) and at Karolinska Insitutet, now focusing on the role of genes outside of the MHC region.
Between 2001-2005 she lead the Multifactrorial disease genetics research group at the Department of Molecular Medicine and Surgery at Karolinska Insitutet and studied genetics of type 1 diabetes, atopic dermatitis, bipolar disease and alcoholism. In 2006 she joined the Neuroimmunology Unit at the Department of Clinical Neuroscience and changed the focus of her research to genetic epidemiology of multiple sclerosis, having since 2014 led the Multiple Sclerosis genetic epidemiology research group. In 2007 she became Associate Professor in genetics. Since 2017 she is coordinating the Horizon 2020 funded MultipleMS project.
During the most recent years Ingrid’s research has focused on
- identification of novel genetic susceptibility variants for multiple sclerosis conducted in collaboration with IMSGC and deCODE genetics
- identification of genetic control of severity/progression of MS which also including investigating novel ways of measuring severity of MS
- identification of interactions between genetic and lifestyle risk factors for MS
- study of the role of viral infections in MS
- identification of novel protein biomarkers for MS
- precision medicine for multiple sclerosis including modeling of MS risk and prognosis of MS
BA (2-1 hon) Natural Sciences (Cell an molecular biology), University of Cambridge, UK 1989
Population-based analysis of the HLA associated risk for IDDM’ Karolinska Institutet 1995
Docent in Genetics, 2007, Karolinska Institutet